Mecasermin rinfabate Pregnancy and Breast Feeding Warnings

Mecasermin rinfabate is also known as: iPlex

Mecasermin rinfabate Pregnancy Warnings

Mecasermin rinfabate has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of embryofetal toxicity or teratogenicity. There are no controlled data in human pregnancy. Mecasermin rinfabate is only recommended for use during pregnancy when benefit outweighs risk.

Mecasermin rinfabate Lactation Warnings

There are no data on the excretion of mecasermin rinfabate into human milk. The manufacturer recommends that caution be used when administering mecasermin rinfabate to nursing women.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.